LRG1 and neoplasm: Unpublished data from our lab show that in addition to the vascular normalization effects, inhibition of LRG1 also promotes tumor infiltration of T-cells by modulating the immunosuppressive tumor microenvironment, thereby supporting a switch from being immunologically “cold” to “hot”.